Difficulty: Medium
Average Score: 83%
Practice
Which of the following preparations combines carbidopa and levodopa in a fixed proportion?
Correct answer
B
Rationale
In the context of safety pharmacology across the lifespan, understanding the combination of carbidopa and levodopa is crucial for managing Parkinson's disease. The correct answer is B) Sinemet. Sinemet is a medication that combines carbidopa and levodopa in a fixed proportion. Carbidopa helps prevent the breakdown of levodopa before it can reach the brain, allowing for more levodopa to enter the brain and be converted to dopamine, thus alleviating Parkinson's symptoms effectively.
Option A) Selegiline is a monoamine oxidase type B (MAO-B) inhibitor used in Parkinson's disease, but it does not contain carbidopa or levodopa. Option C) Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor used in Parkinson's disease, also not containing carbidopa or levodopa. Option D) Biperiden is an anticholinergic medication used to treat Parkinson's disease symptoms related to imbalance of neurotransmitters in the brain, but it does not contain carbidopa or levodopa.
Educationally, knowing the correct combination in Sinemet highlights the importance of understanding how different medications work together to manage complex conditions like Parkinson's disease. This knowledge is vital for healthcare professionals to ensure safe and effective pharmacological interventions across the lifespan of patients with various health needs.
Option A) Selegiline is a monoamine oxidase type B (MAO-B) inhibitor used in Parkinson's disease, but it does not contain carbidopa or levodopa. Option C) Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor used in Parkinson's disease, also not containing carbidopa or levodopa. Option D) Biperiden is an anticholinergic medication used to treat Parkinson's disease symptoms related to imbalance of neurotransmitters in the brain, but it does not contain carbidopa or levodopa.
Educationally, knowing the correct combination in Sinemet highlights the importance of understanding how different medications work together to manage complex conditions like Parkinson's disease. This knowledge is vital for healthcare professionals to ensure safe and effective pharmacological interventions across the lifespan of patients with various health needs.